Mahmut Ekrem Cunetoglu

Mahmut Ekrem Cunetoglu

Auto-generated profile, based on publicly available information

Mahmut Ekrem Cunetoglu

Department of Cardiology Ankara University Ankara Turkey

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2025 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Open access
EBEmir Baskovski
Emir Baskovski
TATimucin Altin
Timucin Altin
OAOmer Akyurek
Omer Akyurek
TTTurkan Seda Tan
Turkan Seda Tan
MEMahmut EkremCunetoglu
Mahmut EkremCunetoglu
ETEralp Tutar
Eralp Tutar
Background: Ventricular fibrillation (VF) is a poorly understood arrhythmia that is one of the main mechanisms of sudden cardiac death in patients with structural heart disease (SHD). Fascicular and Purkinje tissue (FPT) has been implicated in VF. Objective: In this study, we sought to analyze the involvement of FPT colocalized with the scar area of SHD. Additionally, we aimed to investigate outcomes of FPT and scar substrate ablation in SHD VF patients and compare outcomes with VT ablation patients. Methods: This is a retrospective observational study. Clinical and procedural data were collected. Results: Sixteen patients undergoing VF ablation were assigned to the VF group, and their outcomes were compared to those of 170 patients who underwent structural VT ablation. In 15 patients, FPT targets colocalized with low voltage area, LPs, and/or LAVAs. Septal Purkinje and left posterior fascicle were most commonly involved. Procedural metrics were similar with patients undergoing VT ablation. During median follow‐up of 5.5 months (interquartile range [IQR]: 3.5–10), VF recurred in two patients. Conclusion: This study has shown frequent colocalization of FPT with electrophysiologic substrate (late potentials [LPs], low voltage area, etc.) in patients with SHD and VF. We have shown the feasibility of FTP and substrate ablation with good mid‐term outcomes in a small group of patients. Larger studies are necessary for definitive evidence.

23 July 2025 in Postgraduate Medicine
Verified
Journal Article
Closed access
EBEmir Baskovski
Emir Baskovski
TATimucin Altin
Timucin Altin
OAOmer Akyurek
Omer Akyurek
MCMahmut Ekrem Cunetoglu
Mahmut Ekrem Cunetoglu
TTTurkan Seda Tan
Turkan Seda Tan
ETEralp Tutar
Eralp Tutar
Ventricular arrhythmias (VA) are a major cause of sudden cardiac death (SCD) in heart failure patients. It is not known whether readily available clinical markers are of any clinical yield in detecting a subclinical inflammation that may be inflicted in acute arrhythmogenesis. This study aimed to evaluate the prognostic value of inflammatory markers in patients undergoing ventricular tachycardia (VT) catheter ablation and to compare characteristics between those with electrical storm (ES) and elective ablation (EL). This retrospective observational study included patients with structural heart disease undergoing VT ablation. Inflammatory markers (CRP, blood leukocyte, neutrophil, platelet, lymphocyte counts and systemic immune-inflammatory index (SII)) were assessed pre-procedurally. We analyzed procedural outcomes, VT recurrence, mid-term mortality and presence of an electrical storm, correlating these with inflammatory markers. p < 0.05 was considered significant in all analyses. Of 140 patients analyzed (median age 65 ± 15 years; 87.1% males), 63 (45%) had ES and 77(55%) underwent elective ablation. The median ejection fraction was 25%±15.The ES group had significantly higher neutrophil counts and systemic immune-inflammation index (SII) compared to the EL group (p = 0.010 and p = 0.013, respectively). On univariate analysis, elevated SII was associated with mid-term mortality (HR 3.487, p = 0.016), alongside age > 70 years and history of coronary artery bypass grafting (CABG). SII and history of CABG were independent predictors of death on multivariate analysis (HR 1.879, p = 0.018) and (HR: 4.891, p = 0.003), respectively. SII is notably higher in those experiencing ES and is a predictor of mid-term mortality.

29 October 2024 in Journal of Arrhythmia
Verified
Journal Article
Open access
EBEmir Baskovski
Emir Baskovski
TATimucin Altin
Timucin Altin
OAOmer Akyurek
Omer Akyurek
MCMahmut Ekrem Cunetoglu
Mahmut Ekrem Cunetoglu
VKVolkan Kozluca
Volkan Kozluca
ETEralp Tutar
Eralp Tutar
Introduction: Currently, there are no data regarding outcomes of the catheter ablation for structural ventricular tachycardia (VT) in Türkiye. In this observational study, we aim to investigate cardiac outcomes of patients undergoing catheter VT ablation at a tertiary center in Türkiye.Methods: This was a retrospective observational study performed at a single university center. Patients with a confirmed ischemic or non‐ischemic cardiomyopathy, undergoing structural VT ablation were included. Procedural and mid‐term outcomes were analyzed.Results: A total of 124 patients were enrolled in the study. 54(43.5%) patients presented with an electrical storm. During the mean follow‐up of 351 ± 232 days 10(8.1%) patients experienced a recurrence. There was only one peri‐procedural death and cardiac tamponade occurred in two patients.14(11.3%) patients died during the follow‐up, most commonly due to a cardiovascular death. In the multivariate analysis only age >70 was found to be correlated with death during follow‐up, with p =.008, HR = 4.923.Conclusion: A good acute success with low complications was observed in patients undergoing VT ablation for structural heart disease in a tertiary center in Türkiye. Mid‐term outcomes are comparable with international studies with no difference in VT recurrence in ischemic and non‐ischemic patients. Similar to international studies, significant mid‐term mortality was observed.

30 September 2025 in Ankara Üniversitesi Tıp Fakültesi Mecmuası
Verified
Journal Article
Closed access
EBEmir Baskovski
Emir Baskovski
ÖAÖmer Akyürek
Ömer Akyürek
TATimucin Altin
Timucin Altin
MCMahmut Ekrem Cunetoglu
Mahmut Ekrem Cunetoglu
Objectives: Previous studies have demonstrated that nutritional disorders such as obesity and malnutrition are associated with adverse events in patients with a structural heart disease. The impact of these conditions in patients undergoing ventricular tachycardia (VT) ablation is not known. In this study we sought to investigate the effect of obesity and malnutrition on procedural and post-procedural midterm outcomes in patients undergoing VT ablation. Materials and methods: This is a single center, retrospective study which enrolled patients undergoing structural VT ablation. Patients were classified as normal weight, overweight and obese by body mass index (BMI). Malnutrition was defined as prognostic nutritional score (PNI) < 38. Outcomes between groups were compared. Results: A total of 203 patients were enrolled to this study. Among these patients, 54 (25.6%) were normal weight, 102 patients (50.2%) were overweight, and 47 patients (23.1%) were obese. 18 patients (8.8%) were classified as malnourished. No significant difference in VT recurrence was observed across BMI (p=0.335) or nutritional status (p=0.556). However, mortality during follow-up was significantly higher in the malnourished group (50% vs. 7%, p

25 September 2026 in Bozok Tıp Dergisi
Verified
Journal Article
Closed access
VKVolkan Kozluca
Volkan Kozluca
NÖNail Burak Özbeyaz
Nail Burak Özbeyaz
SASeyhmus Atan
Seyhmus Atan
MCMahmut Ekrem Cunetoğlu
Mahmut Ekrem Cunetoğlu
ÇÖÇağdaş Özdöl
Çağdaş Özdöl
Objective: This study aimed to evaluate the association between atherogenic lipid indices and coronary atherosclerotic burden in non-diabetic patients using angiographic scoring systems.Material and Methods: This cross-sectional study included 39 non-diabetic patients with angiographically confirmed coronary artery disease (CAD). The severity and anatomical complexity of coronary lesions were assessed using the Gensini and SYNTAX scoring systems. Patients with previous percutaneous coronary intervention, coronary artery bypass grafting eligibility, impaired ventricular function, significant valvular disease, atrial fibrillation, systemic inflammatory or infectious disease, renal dysfunction, cerebrovascular disease, or use of lipid-lowering therapy were excluded to minimize their potential effects on coronary assessment and lipid indices. Lipid parameters, including triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), very low-density lipoprotein cholesterol (VLDL-C), remnant cholesterol, and atherogenic ratios TG/HDL-C and (TC)/HDL-C), were collected. Associations between lipid indices and angiographic scores were evaluated using Spearman correlation, logistic regression, and ROC analyses.Results: Patients with higher Gensini scores had significantly higher VLDL-C (39.6 vs. 26.9 mg/dL, p=0.03), triglyceride levels (198 vs. 133 mg/dL, p=0.03), TG/HDL-C ratio (4.69 vs. 2.71, p=0.011), and TC/HDL-C ratio (4.74 vs. 4.02, p=0.007), whereas HDL-C was lower (45.1 vs. 54.2 mg/dL, p=0.007). TG/HDL-C [odds ratio (OR) 1.51, 95% confidence interval (CI) 1.03–2.20] and TC/HDL-C (OR 4.30, 95% CI 1.34–13.79) remained independent determinants of higher Gensini categories after multivariable analysis. ROC analyses demonstrated significant discriminative capacity for TG/HDL-C (AUC 0.76) and TC/HDL-C (AUC 0.74). Conclusion: TG/HDL-C and TC/HDL-C ratios were significantly associated with coronary atherosclerotic burden and lesion complexity in non-diabetic patients. These simple and readily accessible indices may be valuable for risk stratification in patients with stable CAD.